Response to "OnabotulinumtoxinA for the treatment of chronic migraine not quite there. . ."

Cephalalgia. 2011 Feb;31(3):378-379. doi: 10.1177/0333102410388530.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Botulinum Toxins, Type A*
  • Chronic Disease
  • Humans
  • Migraine Disorders*
  • Treatment Outcome

Substances

  • Botulinum Toxins, Type A